American Journal of Hematology/Oncology

The 15th Annual International Congress on the Future of Breast Cancer® is less than a week away!

Earn 14.5 CME/CE credits! Find out more and Register here: http://www.gotoper.com/conferences/ibc/meetings/15th-annual-international-congress-on-the-future-of-breast-cancer?mkt_tok=eyJpIjoiTURkalpUYzNaRFU1TUdRNCIsInQiOiJmZlgyNGhMcnlRdU00OW4xMHFmdk1zSXpTY1Z0MGVmU1QxWkdKZzJ1aXpVc0RmZDRxU2ZEZUtZZVRUQU5HK1padmhXRkhIbjcyUnJQeTBlUjdtVzVqQ2ZsTzRoK2xSdjRiR2tjN1RSS0JOVT0ifQ%3D%3D

Community Practice Connections™: 1st Annual School of Gastrointestinal Oncology™



See the full online CME activity here:

http://www.gotoper.com/online-cme-activities/sogo/community-practice-connections-1st-annual-school-of-gastrointestinal-oncology?mkt_tok=eyJpIjoiWm1KaFpqVTJNakl4WmpBNSIsInQiOiJtemlRclE5NEgyODh0T0p6R2hJOHE5czlsVUMwVFo3Q0NhNXJcLytZNTVhOUVLcHl6cUM2VVoxRWZtczUyOGdVUW83NitRcTdYaFhTY1pZZElxV0xBMVwvbjZTSHMrOTVaWk9LZmMzMlZnUklZPSJ9

Cancer Patients Benefit from CURE Media Group Adding Six Leading Organizations to Advocacy Spotlight Partnership Program


http://www.prweb.com/releases/CURESixNew/Partners/prweb13533131.htm

Cancer Patients Benefit from CURE Media Group Adding Six Leading Organizations to Advocacy... PLAINSBORO, N.J. (PRWEB) July 06, 2016 -- Collaborations to Deliver Unique Patient-Focused Cancer Content

Community Practice Connections™: Working Group to Advance the Treatment of Triple-Negative... Physicians' Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Personalizing Therapy for Acquired Resistance to EGFR Kinase Inhibitors in Advanced NSCLC



The management of EGFR mutant NSCLC with acquired resistance to EGFR Kinase inhibitor therapy is becoming increasingly challenging. The development of multiple promising treatment strategies, including novel third-generation EGFR kinase inhibitors, has added to both treatment options and complexity. Careful assessment of the underlying mechanism of acquired resistance to initial therapy are central to selecting optimal subsequent treatment. In all cases, potential strategies for therapy must be adapted to individual patient and disease characteristics.

Read more at: http://www.gotoper.com/publications/ajho/2016/2016Apr/Personalizing-Therapy-for-Acquired-Resistance-to-EGFR-Kinase-Inhibitors-in-Advanced-NSCLC

Personalizing Therapy for Acquired Resistance to EGFR Kinase Inhibitors in Advanced NSCLC |... The management of EGFR mutant NSCLC with acquired resistance to EGFR Kinase inhibitor therapy is becoming increasingly challenging. The development of multiple promising treatment strategies, including novel third-generation EGFR kinase inhibitors, has added to both treatment options and complexity....

We are happy to announce that registration is open for the 1st Annual European Congress on Hematology: Focus on Lymphoid Malignancies!



http://www.prweb.com/releases/PERGlobal/ParisLaunch/prweb13455648.htm

Find out more and register here: http://www.gotoper.com/conferences/ECH/meetings/1st-Annual-European-Congress-on-Hematology-Focus-on-Lymphoid-Malignancies/registration

PER Global Launches Second 2016 European Congress, First Annual European Congress on Hematology:... PLAINSBORO, N.J. (PRWEB) June 02, 2016 -- Registration Now Open for “Paris Lymphoma” Congress

Cancer Summaries and Commentaries™: Updates from Singapore: Advances in Personalized Lung Cancer... Physicians' Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Earn 2.0 Contact Hours in Chicago at the Oncogenic Tumor Board in NSCLC on June 5th!



http://www.gotoper.com/conferences/asconsclc16/meetings/Oncogenic-Tumor-Board-in-NSCLC-Targeting-Driver-Mutations-to-Maximize-Therapeutic-Outcomes

CURE Media Group Launches CURE Connections Video Series for National Skin Cancer Detection and... PLAINSBORO, N.J. (PRWEB) May 24, 2016 -- CURE Connections Video Series Raises Awareness on Prevention and Early Detection of Skin Cancers

Pembrolizumab 3-Year Survival Rate Hits 40% in Melanoma



Read more from OncLive:
http://www.onclive.com/conference-coverage/asco-2016/pembrolizumab-3year-survival-rate-hits-40-in-melanoma?e5=3db330935d12d19b0ca809c54efbbdd4&sao=7&utm_source=Informz&utm_medium=OncLive&utm_campaign=ASCO%20CONF.%20eNews_Alimta,%20Lilly_05/18/2016

Pembrolizumab 3-Year Survival Rate Hits 40% in Melanoma | Onclive Forty percent of patients with advanced melanoma who started taking pembrolizumab during the clinical trial that led to its initial approval were still alive after 3 years, with many responders in remission even after stopping treatment.

Bonnie J. Addario Lung Cancer Foundation and OncLive Attack Lung Cancer with Lung Grant Tank... SAN CARLOS, Calif., May 18, 2016 /PRNewswire-USNewswire/ -- Today, the Bonnie J. Addario Lung Cancer Foundation...

CURE Media Group Welcomes Imerman Angels Support Network to Advocacy Spotlight Partnership Program PLAINSBORO, N.J. (PRWEB) May 05, 2016 -- Partnership Expands Outreach and Information for Patients Seeking Allies in Fight Against Cancer

Fibroblast Growth Factor Receptor (FGFR) as a Therapeutic Target in Lung and Head and Neck Cancer



Read more at: http://www.gotoper.com/publications/ajho/2016/2016Mar/Fibroblast-Growth-Factor-Receptor-FGFR-as-a-Therapeutic-Target-in-Lung-and-Head-and-Neck-Cancer

Fibroblast Growth Factor Receptor (FGFR) as a Therapeutic Target in Lung and Head and Neck... The American Journal of Hematology/Oncology is a monthly peer-reviewed publication that provides original research, reviews, and editorial/commentaries that address cutting-edge developments in genomics, targeted therapies, molecular diagnostics, and pathways related to oncological science and clini…

CURE Media Group Names Lynne Malestic of Eisenhower Lucy Curci Cancer Center (Calif.) as 2016 CURE Extraordinary Healer for Oncology Nursing

CURE magazine

http://www.prweb.com/releases/2016EHWinner/Malestic/prweb13379657.htm

CURE Media Group Names Lynne Malestic of Eisenhower Lucy Curci Cancer Center (Calif.) as 2016... PLAINSBORO, N.J. (PRWEB) April 29, 2016 -- Malestic Chosen from More than 50 Nominations Nationwide

Karen Matijevich, RN on Unique Kinetics of Immuno-Oncology Strategies: What Everyone Needs to Know - See more at: http://www.gotoper.com/conferences/ONSS16IO/meetings/Nursing-Opportunities-to-Improve-Outcomes-in-the-Application-of-Immuno-Oncology-Strategies-A-Practical-Approach-to-Care/agenda

Joanne Riemer, RN, BSN on Assessment of Immune-Related Adverse Events to Proactively Counsel and Mitigate Impact on Optimized Care - See more at: http://www.gotoper.com/conferences/ONSS16IO/meetings/Nursing-Opportunities-to-Improve-Outcomes-in-the-Application-of-Immuno-Oncology-Strategies-A-Practical-Approach-to-Care/agenda

Dr Patrick Forde on Checkpoint Inhibition in the Management of Solid Tumors – Updates for Nurses - See more at: http://www.gotoper.com/conferences/ONSS16IO/meetings/Nursing-Opportunities-to-Improve-Outcomes-in-the-Application-of-Immuno-Oncology-Strategies-A-Practical-Approach-to-Care/agenda

Nursing Opportunities to Improve Outcomes in the Application of Immuno-Oncology Strategies: A...

Dr Jason Luke on Checkpoint Inhibition in the Management of Solid Tumors – Updates for Nurses - See more at: http://www.gotoper.com/conferences/ONSS16IO/meetings/Nursing-Opportunities-to-Improve-Outcomes-in-the-Application-of-Immuno-Oncology-Strategies-A-Practical-Approach-to-Care/agenda

Full house at PER's Nursing Opportunities to Improve Outcomes in the Application of Immuno-Oncology Strategies: A Practical Approach to Care - See more at: http://www.gotoper.com/conferences/ONSS16IO/meetings/Nursing-Opportunities-to-Improve-Outcomes-in-the-Application-of-Immuno-Oncology-Strategies-A-Practical-Approach-to-Care

Dr Jason Luke kicking off the Nursing Opportunities to Improve Outcomes in the Application of Immuno-Oncology Strategies: A Practical Approach to Care - http://www.gotoper.com/conferences/ONSS16IO/meetings/Nursing-Opportunities-to-Improve-Outcomes-in-the-Application-of-Immuno-Oncology-Strategies-A-Practical-Approach-to-Care

Neoadjuvant and Adjuvant Chemotherapy Considerations for Triple-Negative Breast Cancer



Read more here:

http://www.gotoper.com/publications/ajho/2016/2016Mar/Neoadjuvant-and-Adjuvant-Chemotherapy-Considerations-for-Triple-Negative-Breast-Cancer

Immunotherapy Doubts Fading in GI Cancers

Read more from the 1st Annual School of Gastrointestinal Oncology here.

http://www.onclive.com/conference-coverage/SOGO-2016/immunotherapy-doubts-fading-in-gi-cancers?utm_source=Informz&utm_medium=OncLive&utm_campaign=SOGO_Conference_eNews_Stivarga_Bayer_4-26-16

Immunotherapy Doubts Fading in GI Cancers Immunotherapy approaches are showing early signs of activity against a range of gastrointestinal cancers, defying the skeptical view that these tumors would not respond to the emerging agents succeeding in other malignancies.

Thank you to the chairs, faculty, and all of the attendees for an awesome 1st Annual School of Gastrointestinal Oncology™! We look forward to seeing you next year! http://www.gotoper.com/conferences/SOGO/meetings/1st-Annual-School-of-Gastrointestinal-Oncology/agenda

Dr Christopher Heery answers Immunotherapy - The Next Great Tool in GI Cancer? at the 1st Annual School of Gastrointestinal Oncology™ in New York City http://www.gotoper.com/conferences/SOGO/meetings/1st-Annual-School-of-Gastrointestinal-Oncology/agenda

Community Outreach and Advocacy Groups at the 1st Annual School of Gastrointestinal Oncology™ in New York City http://www.gotoper.com/conferences/SOGO/meetings/1st-Annual-School-of-Gastrointestinal-Oncology/agenda

Drs Wells Messersmith on 2016 Hot Topics in Oncology at the 1st Annual School of Gastrointestinal Oncology™ in New York City http://www.gotoper.com/conferences/SOGO/meetings/1st-Annual-School-of-Gastrointestinal-Oncology/agenda

Dr Ghassan Abou-Alfa on Recent Updates in Treating Hepatocellular Carcinoma - See more at: http://www.gotoper.com/conferences/SOGO/meetings/1st-Annual-School-of-Gastrointestinal-Oncology/agenda .ZIWkJuGf.dpuf at the 1st Annual School of Gastrointestinal Oncology™ in New York City http://www.gotoper.com/conferences/SOGO/meetings/1st-Annual-School-of-Gastrointestinal-Oncology/agenda

Dr Choti and Dr Abou-Alfa discuss Updates in the Management of Locoregional Gastric Cancer http://www.gotoper.com/conferences/SOGO/meetings/1st-Annual-School-of-Gastrointestinal-Oncology/agenda

Massey Nematollahi, Jessica Mitchell, & Dr John Marshall Oral Targeted Agents: Assuring Adherence at the 1st Annual School of Gastrointestinal Oncology™ in New York City http://www.gotoper.com/conferences/SOGO/meetings/1st-Annual-School-of-Gastrointestinal-Oncology/agenda

Dr David Bartlett on HI-PEC for GI Cancers at the 1st Annual School of Gastrointestinal Oncology™ in New York City http://www.gotoper.com/conferences/SOGO/meetings/1st-Annual-School-of-Gastrointestinal-Oncology/agenda